KR830007716A - Method for preparing 3-amide substituted steroid derivatives - Google Patents

Method for preparing 3-amide substituted steroid derivatives Download PDF

Info

Publication number
KR830007716A
KR830007716A KR1019810004462A KR810004462A KR830007716A KR 830007716 A KR830007716 A KR 830007716A KR 1019810004462 A KR1019810004462 A KR 1019810004462A KR 810004462 A KR810004462 A KR 810004462A KR 830007716 A KR830007716 A KR 830007716A
Authority
KR
South Korea
Prior art keywords
group
carbon atoms
hydrogen
amino
methyl
Prior art date
Application number
KR1019810004462A
Other languages
Korean (ko)
Other versions
KR880001239B1 (en
Inventor
데라에뜨 로제르
뻬르또 폴레리 베스
벤조니 조세뜨
Original Assignee
허버트 후리휄
로우셀 우크라프
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 허버트 후리휄, 로우셀 우크라프 filed Critical 허버트 후리휄
Publication of KR830007716A publication Critical patent/KR830007716A/en
Application granted granted Critical
Publication of KR880001239B1 publication Critical patent/KR880001239B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J41/00Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J13/00Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17
    • C07J13/007Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17 with double bond in position 17 (20)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J41/00Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0005Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring the nitrogen atom being directly linked to the cyclopenta(a)hydro phenanthrene skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J41/00Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0005Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring the nitrogen atom being directly linked to the cyclopenta(a)hydro phenanthrene skeleton
    • C07J41/0027Azides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J43/00Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J43/003Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

내용 없음No content

Description

3-아미드 치환 스테로이드 유도체의 제조방법Method for preparing 3-amide substituted steroid derivatives

본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음Since this is an open matter, no full text was included.

Claims (7)

다음의 구조식(Ⅱ)와 같은 아민을, 구조식(Ⅲ)과 같은 할리드와 반응시켜서 R2가 수소이고, R3가 탄소수 2-8인 알콕시카보닐기나 아실기인 구조식(Ⅰ)의 화합물을 얻고 이를 분리시켜 필요한 경우 염화시키거나, 또는 그 아민기가 산가수분해에 의해 용이하게 분열될 수 있는 그룹으로 보호되어 있는 2나 3단위의 α-아미노산을 갖는 펩 타이드나 α-아미노산과 반응시켜 얻은 생성물을 처리하여 R2가 수소이고,R3가 2나 3단위의 α-아미노산을 갖는 펩타이드나 α-아미노산으로부터 유도된 기인 구조식(Ⅰ)과 같은 화합물을 얻고 이를 분리시켜 필요할 경우 염화시키거나, 또는 탄소수 2-5인 하이드록시알킬 할리드나 C2-C5의 알킬할리드(이때의 할로겐은 염소, 브롬, 또는 요오드이다)와 반응시켜서 R2가 R3가 수소, 또는 탄소수 1-5인 알킬기, 혹은 탄소수 2-5인 하이드록시 알킬기인 구조식(Ⅰ)의 화합물을 얻어서 이를 분리 및 염화시키거나, 또는 R3가 수소인 경우에는 다음의 구조식(Ⅳ)와 같은 할리드와 반응시켜 R2가 C1-C5인 알킬기이거나 탄소수 2-5인 하이드록시알킬기이고 R3가 탄소수 1-5인 알킬기이거나 탄소수 2-5인 하이드록시알킬 또는 탄소수 2-8인 아실옥시나 아실기인 구조식(Ⅰ)의 화합물을 얻거나, 또는 R3가 수소인 경우에는 구조식(Ⅰ)과 같은 앞서의 화합물을 2나 3단위의 α-아미노산을 함유하는 펨타이드나 α-아미노산과 반응시켜 얻은 생성물을 처리하여 R2가 탄소수 1-5인 알킬기이거나 탄소수 2-5인 하이드록시 알킬기이고, R3는 2나 3단위의 α-아미노산을 함유하는 펩타이드나 α-아미노산으로부터 유도된 기인 구조식(Ⅰ)과 같은 화합물을 얻은 다음 이를 분리시켜 필요할 경우 염화시키는 것을 특징으로 하는 다음의 구조식(Ⅰ)과 같은 3-아미노치환 스테로이드 유도체의 제조방법.An amine such as the following formula (II) is reacted with a halide such as formula (III) to obtain a compound of formula (I) wherein R 2 is hydrogen and R 3 is an alkoxycarbonyl or acyl group having 2 to 8 carbon atoms. A product obtained by separating and chlorinating if necessary or reacting with a peptide or α-amino acid having 2 or 3 units of α-amino acid in which the amine group is protected by a group which can be readily cleaved by acid hydrolysis. To obtain a compound of formula (I), wherein R 2 is hydrogen, R 3 is a peptide having 2 or 3 units of α-amino acid or a group derived from α-amino acid, and is separated and chlorinated if necessary, or 2-5 carbon atoms, a hydroxyalkyl Harley and out C 2 -C 5 alkyl leads to a (wherein the halogen is chlorine, bromine, or iodine) by reaction with R 2 is R 3 is hydrogen, or an alkyl group having a carbon number of 1-5, Or carbon number Obtain a compound of formula (I) which is a hydroxy alkyl group of 2-5, separate and chlorine it, or when R 3 is hydrogen, react with a halide such as the following formula (IV) to make R 2 C 1- A compound of formula (I) wherein the alkyl group is C 5 or a hydroxyalkyl group having 2 to 5 carbon atoms and R 3 is an alkyl group having 1 to 5 carbon atoms or a hydroxyalkyl having 2 to 5 carbon atoms or an acyloxy or acyl group having 2 to 8 carbon atoms. Or when R 3 is hydrogen, the product obtained by reacting a preceding compound, such as formula (I), with a femide or α-amino acid containing 2 or 3 units of α-amino acid, and then R 2 An alkyl group having 1 to 5 or a hydroxy alkyl group having 2 to 5 carbon atoms, R 3 is a peptide derived from a peptide containing 2 or 3 units of α-amino acid or a compound derived from α-amino acid, and then obtained. To separate salt if necessary Method of producing a 3-amino-substituted steroid derivatives, such that the following formula (Ⅰ), characterized in that. 상기 구조식에서 :In the above structural formula: W는 수소나 하이드록실기, 또는 X와 함께 에틸리덴기를 나타내고,W represents an ethylidene group together with hydrogen, a hydroxyl group, or X, X는 에틸기, 또는그룹이며 혹은, W와 함께 에틸리덴기를 나타내고 파형선을 해당되는 기가 α와 B구조중어느 하나로 존재함을 의미하며, R1은 수소나 메틸기이고,X is an ethyl group, or I A group or, together with W, represents an ethylidene group and indicates that the corresponding group is present in either of α and B structures, R 1 is hydrogen or methyl, R2는 수소, 탄소수 1-5인 알킬기, 또는 탄소수 2-5인 하이드록시 알킬기이며,R 2 is hydrogen, an alkyl group having 1 to 5 carbon atoms, or a hydroxy alkyl group having 2 to 5 carbon atoms, R3는 수소, 탄소수 1-5인 알킬기, 탄소수 2-5인 하이드록시알킬기, 탄소수 2-8인 알콕시카보닐기나 또는 2나 3단위의 α-아미노산을 함유하는 펩타이드나 α-아미노으로부터 유도된 기로서, R2나 R3중 적어도 어느 하나는 수소가 아니며, 다른 한편으로는,R 3 is derived from a peptide or α-amino containing hydrogen, an alkyl group of 1-5 carbon atoms, a hydroxyalkyl group of 2-5 carbon atoms, an alkoxycarbonyl group of 2-8 carbon atoms, or an α-amino acid of 2 or 3 units. As a group, at least one of R 2 and R 3 is not hydrogen, on the other hand, i) R1이 메틸기, W와 R2가 수소, 그리고 X가기인 경우, R3는 메틸이나 아실기 또는 아미노카복실산으로부터 유도된 잔사를 나타낼 수 없으며,i) R 1 is a methyl group, W and R 2 are hydrogen, and X is If a group, R 3 cannot represent a residue derived from methyl or an acyl group or aminocarboxylic acid, ii) R1이 메틸기, W가 수소, R2가 메틸기이고 X가기인 경우, R3는 메틸기나 아세틸기를 나타 낼 수 없고,ii) R 1 is methyl, W is hydrogen, R 2 is methyl and X is In the case of a group, R <3> cannot represent a methyl group or an acetyl group, iii) R1이 메틸기, R2와 W가 수소, X가(이때의 하이드록실기는(s)구조이다) 그룹이며 아미노기가 3α 위치에 있는 경우 R3는 메틸, 아세틸, 또는 글리실기를 나타낼 수 없으며,iii) R 1 is a methyl group, R 2 and W are hydrogen, X is (The hydroxyl group at this time is a (s) structure) If the amino group is in the 3α position R 3 can not represent a methyl, acetyl, or glycyl group, iv) W가 수소, X가그룹이고 아미노기가 3α우치에 있는 경우, 치환제 R1,R2및 R3는 동시에 메틸기를 나타낼 수 없고,iv) W is hydrogen, X is When the group and the amino group are in the 3α round, the substituents R 1 , R 2 and R 3 cannot simultaneously represent a methyl group, v) R2와 W가 수소, R1이 메틸기, 그리고 X 가(이때의 하이드록실기는 (R)구조이다) 그룹이며, 아미노기가 3α 위치에 있으면 R3는 에톡시카보닐, 메틸, 또는 아세틸기를 나타낼 수 없으며,v) R 2 and W are hydrogen, R 1 is a methyl group, and X is (A hydroxyl group at this time is a (R) structure). When the amino group is in the 3α position, R 3 cannot represent an ethoxycarbonyl, methyl, or acetyl group. vi) R1,R2및 R3가 동시에 메틸기이고 아미노기가 3α 위치에 있으면 W와 X는 에틸기덴기를 이룰 수었다.vi) When R 1 , R 2 and R 3 are methyl groups at the same time and the amino group is in the 3α position, W and X can form an ethylidene group. 한편 R3'는 탄소수 2-8인 알콕시카보닐기나 아실기이며, R3"는 탄소수 1-5인 알킬기, 탄소수 2-5인 하이드록시알킬기, 또는 탄소수 2-8인 알콕시카보닐기이고, Hal은 염소, 브롬, 혹은 요오드이다.R 3 ′ is an alkoxycarbonyl group or acyl group having 2 to 8 carbon atoms, R 3 ″ is an alkyl group having 1 to 5 carbon atoms, a hydroxyalkyl group having 2 to 5 carbon atoms, or an alkoxycarbonyl group having 2 to 8 carbon atoms, and Hal Is chlorine, bromine or iodine. 아미노그룹의 보호그룹이 3차부틸옥시카보닐기인 상기 1항의 방법.The method of claim 1, wherein the protecting group of the amino group is a tertiary butyloxycarbonyl group. X가그룹인 구조식(Ⅱ)의 화합물의 유도체가 출발물질로 사용되는 상기 1항의 방법.X The method of claim 1, wherein a derivative of the compound of formula II which is a group is used as starting material. X가그룹인 구조식(Ⅲ)의 화합물의 유도체가 출발물질로 사용되는 상기 1항의 방법.X The method of claim 1, wherein a derivative of the compound of formula III, which is a group, is used as starting material. 그 명칭이 다음과 같은 구조식(Ⅰ)의 화합물의 유도체가운데 어느 하나를 제조하는 상기 1항의 방법.The method of claim 1, wherein one of the derivatives of the compound of formula (I) is named. -(2S) 2-아미노 N-[(20S)-하이드록시 (5α)-프레그난-3 α-닐] 1H-인돌 3-프로판아미드.-(2S) 2-Amino N-[(20S) -hydroxy (5a) -pregnan-3 a-yl] 1H-indole 3-propanamide. -(2S) 2-아미노 N-[(20S)-20-하이드록시 (5α)-프레그난-3α)-닐] 1H-인돌 3-프로판아미드.-(2S) 2-Amino N-[(20S) -20-hydroxy (5α) -pregnan-3α) -yl] 1H-indole 3-propanamide. -2-아미노 N-[(20S)-20-하이드록시-19 노르 (5α)-프레그난-3α-닐] 아세트아미드, 그리고, -2-아미노 N-[(20S)-20-하이드록시 (5α)-프레그난-3α-닐] N-메틸 아세트 아미드 및 이들의 무기나 유기산과의 부가염.2-amino N-[(20S) -20-hydroxy-19-nor (5α) -pregnan-3α-yl] acetamide, and 2-amino N-[(20S) -20-hydroxy ( 5α) -pregnan-3α-yl] N-methyl acetamide and addition salts thereof with inorganic or organic acids. 구조식(Ⅰ)과 같은 화합물의 유도체나 이들의 부가염 가운데 적어도 한가지를 활성성분으로 함유하는 특징이 있는 조성물의 제조방법.A method for producing a composition characterized by containing at least one of a derivative of the compound of formula (I) or an addition salt thereof as an active ingredient. 그 활성성분이 (2S) 2-아미노 N-1 (20S)-20 하이드록시 (5α) 프레그닌-3α-닐/1H-인돌3-프로티아미드로 구성되는 상기 6항의 방법.The method according to the above 6, wherein the active ingredient consists of (2S) 2-amino N-1 (20S) -20 hydroxy (5α) pregnin-3α-yl / 1H-indole3-protiamide. ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.※ Note: The disclosure is based on the initial application.
KR1019810004462A 1980-11-21 1981-11-18 Process for the preparation of 3 amino substituted derivatives KR880001239B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8024750A FR2494698A1 (en) 1980-11-21 1980-11-21 NOVEL SUBSTITUTED 3-AMINO STEROID DERIVATIVES, THEIR SALTS, PREPARATION METHOD, MEDICAMENT APPLICATION AND COMPOSITIONS COMPRISING THE SAME
FR80-24750 1980-11-21

Publications (2)

Publication Number Publication Date
KR830007716A true KR830007716A (en) 1983-11-04
KR880001239B1 KR880001239B1 (en) 1988-07-12

Family

ID=9248226

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019810004462A KR880001239B1 (en) 1980-11-21 1981-11-18 Process for the preparation of 3 amino substituted derivatives

Country Status (23)

Country Link
JP (1) JPS57116099A (en)
KR (1) KR880001239B1 (en)
AT (1) AT389703B (en)
AU (1) AU546100B2 (en)
BE (1) BE891201A (en)
CA (1) CA1175415A (en)
CH (1) CH651056A5 (en)
DE (1) DE3146117A1 (en)
DK (1) DK161093C (en)
ES (1) ES8207195A1 (en)
FI (1) FI77871C (en)
FR (1) FR2494698A1 (en)
GB (1) GB2087894B (en)
HU (1) HU184896B (en)
IE (1) IE52188B1 (en)
IL (1) IL64224A0 (en)
IT (1) IT1172086B (en)
LU (1) LU83781A1 (en)
NL (1) NL8105260A (en)
PT (1) PT74015B (en)
SE (1) SE451456B (en)
SU (1) SU1327789A3 (en)
ZA (1) ZA817806B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9084800B2 (en) * 2011-11-07 2015-07-21 Natreon, Inc. Indolealkylamino-withasteroid conjugates and method of use

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2430467A (en) * 1944-02-11 1947-11-11 Glidden Co 3-amino-derivatives of steroids and method of making same
US2781342A (en) * 1952-05-17 1957-02-12 Upjohn Co Steroid enamines
GB962324A (en) * 1959-09-12 1964-07-01 Clin Byla Ets Steroid compounds and production thereof
FR1311761A (en) * 1959-09-12 1962-12-14 Clin Byla Ets Amino compounds of the steroid series and method of preparing such compounds
NL103735C (en) * 1961-02-17
US3503959A (en) * 1962-03-30 1970-03-31 Sterling Drug Inc 3-amino steroids
US3196168A (en) * 1964-02-18 1965-07-20 American Home Prod Aminoaroyl aminosteroids
BE647858A (en) * 1964-05-13
US3196169A (en) * 1964-11-03 1965-07-20 American Home Prod Aminoacyl aminosteroids
BE672238A (en) * 1965-11-12 1966-03-01
BE811304R (en) * 1973-10-24 1974-06-17 PREPARATION PROCEDURE FOR (20 S) 3 BETA -N-DIMETHYLAMINO
FR2463777A1 (en) * 1979-08-17 1981-02-27 Roussel Uclaf NOVEL DERIVATIVES OF 5A-PREGNAN-20-OL, PROCESS FOR PREPARING THEM AND THEIR APPLICATION AS MEDICAMENTS

Also Published As

Publication number Publication date
DK161093C (en) 1991-11-18
IT8149746A0 (en) 1981-11-20
AU7772381A (en) 1982-05-27
ATA497081A (en) 1989-06-15
SU1327789A3 (en) 1987-07-30
AU546100B2 (en) 1985-08-15
DK514981A (en) 1982-05-22
FR2494698A1 (en) 1982-05-28
HU184896B (en) 1984-10-29
BE891201A (en) 1982-05-21
AT389703B (en) 1990-01-25
CA1175415A (en) 1984-10-02
PT74015A (en) 1981-12-01
FR2494698B1 (en) 1983-06-24
GB2087894B (en) 1984-09-26
IE812732L (en) 1982-05-21
FI77871C (en) 1989-05-10
NL8105260A (en) 1982-06-16
ES507309A0 (en) 1982-09-01
SE8105995L (en) 1982-05-22
FI77871B (en) 1989-01-31
SE451456B (en) 1987-10-12
IE52188B1 (en) 1987-08-05
CH651056A5 (en) 1985-08-30
FI813677L (en) 1982-05-22
DK161093B (en) 1991-05-27
PT74015B (en) 1983-11-30
LU83781A1 (en) 1982-06-30
GB2087894A (en) 1982-06-03
JPS57116099A (en) 1982-07-19
IT1172086B (en) 1987-06-18
ES8207195A1 (en) 1982-09-01
KR880001239B1 (en) 1988-07-12
IL64224A0 (en) 1982-02-28
JPH0247479B2 (en) 1990-10-19
DE3146117A1 (en) 1982-06-16
ZA817806B (en) 1982-10-27

Similar Documents

Publication Publication Date Title
Fujii et al. Studies on the synthesis of histidine peptides. I. N Im-Tosylhistidine derivatives as starting materials
KR880000433A (en) Method for preparing imidazopyridine and intermediate compound
KR950701918A (en) N-β-hydroxyalkyl-tri-N-carboxyalkyl-1,4,7,10-teazacyclododecane and N-β-hydroxyalkyl-tri-N-carboxyalkyl-1,4,8, Process for Producing N-β-Hydroxyalkyl-Tri-N-Carboxyalkyl-1,4,7,10-Tetraazacyclododecane and N-β-Hydroxyalkyl-Tri-N -Carboxyalkyl-1,4,8,11-Tetraazacyclotetradecane Derivatives and Their Metal Complexes
KR870004019A (en) Method for preparing quinoline derivative
KR850001725A (en) Method for preparing carboxylic ester
KR850004472A (en) Method for preparing 4H-3, I-benzoxazin-4-one derivative
KR850001767A (en) Preparation of Steroids
KR840007011A (en) Process for preparing cefem compound
KR840004113A (en) Method for preparing 7-acylamino-3-cepem-4-carboxylic acid derivative
KR850005845A (en) Process for preparing 7-amino-3-substituted-methyl-3-cepem-4-carboxylic acid and lower alkylsilyl derivatives thereof
KR840005733A (en) Method for preparing muramyl peptide
KR830007716A (en) Method for preparing 3-amide substituted steroid derivatives
KR850002459A (en) Dihydroxybenzamide derivatives and preparation method thereof
KR840006254A (en) Method for preparing 7-substituted-3-vinyl-3-cefem compound
KR850007586A (en) Method for preparing pyrrolidone derivatives
KR860008185A (en) Process for preparing penem compound
KR840007869A (en) Novel derivatives of N-aminopyridinium betaines and preparation methods thereof and pharmaceutical compositions containing them
KR900009661A (en) Ergoline derivatives
KR830007633A (en) Method for preparing bis-tetrazole methyl thiol
KR880012544A (en) Benzenesulfonamide Derivatives and Preparation Methods Thereof
KR960029324A (en) Method for preparing 5-substituted 2-chloropyridine
KR830008489A (en) Method for preparing N-acyl amino acid derivative
US3445447A (en) Tert-amyloxycarbonyl derivatives of amino acids
KR880701240A (en) New Improved Method of Preparation of Peniclanic Acid Derivatives
US3060204A (en) Substituted androst-5-enes, salts and methods of preparing the same